Jennifer Olson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3266 17th Ave Ne, Arvilla, ND 58214 Phone: 218-779-6695 |
News Archive
A new study published in the journal JAMA Internal Medicine in May 2020 reports that false comparisons between the count of COVID-19 deaths as reported by various hospitals in the US, and the estimated flu-related deaths, causes significant confusion and may impair the ability to design public health policies.
Scientists at UC Irvine reported this week that a synthetic compound ShK-186, originally derived from a sea anemone toxin, has been found to enhance metabolic activity and shows potential as a treatment for obesity and insulin resistance.
Lapmaster Group Holdings LLC, a leading supplier of high-precision equipment and services for lapping, polishing, grinding, and honing, announced today that it has acquired Peter Wolters GmbH, a provider of machine tools and systems for high-precision surface processing.
A new study has found a simple way to reduce the risk of premature babies being born with cerebral palsy.
Cornerstone Pharmaceuticals, Inc. has announced the publication of data from preclinical studies on EmPAC™, its nanoparticle reformulation of paclitaxel, in the August issue of the Journal of Nanoscience and Nanotechnology. The publication highlights data demonstrating improved safety and efficacy of EmPAC™ versus Taxol®, the generic formulation of paclitaxel and one of the most widely prescribed chemotherapies. EmPAC™ is a nanoemulsion formulation of Paclitaxel and is the lead product candidate of Cornerstone's proprietary Emulsiphan™ cancer selective delivery nanotechnology platform. Taxol®, an injectable formulation of Paclitaxel, is currently used to treat a variety of cancers, including ovarian carcinomas, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma.
› Verified 4 days ago